Edition:
United States

Analysts: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

3.48USD
27 May 2016
Change (% chg)

-- (--)
Prev Close
$3.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
333,476
52-wk High
$5.88
52-wk Low
$2.59

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.22 December 31 May 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.17 2.17 2.17 2.17

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 6 2.17 4.07 0.20 --
Quarter Ending Sep-16 6 2.00 3.20 0.30 --
Year Ending Dec-16 6 9.66 14.65 3.80 2.64
Year Ending Dec-17 6 12.65 23.00 6.33 26.28
Earnings (per share)
Quarter Ending Jun-16 6 -0.22 -0.18 -0.28 --
Quarter Ending Sep-16 6 -0.23 -0.21 -0.28 --
Year Ending Dec-16 6 -0.89 -0.76 -1.03 -0.81
Year Ending Dec-17 6 -0.92 -0.59 -1.17 -0.48

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 1.62 3.03 1.41 86.73
Quarter Ending Dec-15 4.97 1.73 3.24 65.17
Quarter Ending Sep-15 1.75 15.43 13.68 781.60
Quarter Ending Jun-15 0.22 1.92 1.70 774.55
Quarter Ending Mar-15 0.10 0.18 0.08 81.00
Earnings (per share)
Quarter Ending Mar-16 -0.20 -0.25 0.05 -22.55
Quarter Ending Dec-15 -0.10 -0.24 0.14 -140.00
Quarter Ending Sep-15 -0.23 0.12 0.35 -152.56
Quarter Ending Jun-15 -0.26 -0.20 0.06 -22.48
Quarter Ending Mar-15 -0.28 -0.23 0.05 -18.44

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 2.17 2.17 1.66 1.74 --
Quarter Ending Sep-16 2.00 2.00 1.64 1.72 --
Year Ending Dec-16 9.66 9.66 6.54 6.86 2.64
Year Ending Dec-17 12.65 12.64 11.12 11.43 26.28
Earnings (per share)
Quarter Ending Jun-16 -0.22 -0.22 -0.21 -0.22 --
Quarter Ending Sep-16 -0.23 -0.23 -0.22 -0.22 --
Year Ending Dec-16 -0.89 -0.89 -0.83 -0.84 -0.81
Year Ending Dec-17 -0.92 -0.92 -0.81 -0.76 -0.48

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 1 2
Quarter Ending Sep-16 0 0 2 0
Year Ending Dec-16 0 0 4 0
Year Ending Dec-17 1 0 3 0
Earnings
Quarter Ending Jun-16 0 0 1 3
Quarter Ending Sep-16 0 0 1 3
Year Ending Dec-16 0 0 2 3
Year Ending Dec-17 0 0 2 2

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.